litlas
Log inCreate account

Merlin C. Thomas

Active 1982–2025

107
Papers
18,309
Citations
80
h-index
105
i10-index

Citations

Citations per year for Merlin C. Thomas1984: 2 citations1985: 2 citations1992: 1 citations1998: 1 citations1999: 3 citations2000: 3 citations2001: 6 citations2002: 11 citations2003: 26 citations2004: 63 citations2005: 73 citations2006: 140 citations2007: 108 citations2008: 143 citations2009: 140 citations2010: 180 citations2011: 210 citations2012: 173 citations2013: 236 citations2014: 240 citations2015: 225 citations2016: 167 citations2017: 201 citations2018: 168 citations2019: 540 citations2020: 917 citations2021: 718 citations2022: 489 citations2023: 377 citations2024: 585 citations2025: 304 citations2026: 9 citations1986–1991: no citations, so these years are not shown1993–1997: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,617 citing papers, 18.8% of this breakdownChina: 1,130 citing papers, 13.1% of this breakdownAustralia: 611 citing papers, 7.1% of this breakdownUnited Kingdom: 500 citing papers, 5.8% of this breakdownItaly: 411 citing papers, 4.8% of this breakdownGermany: 360 citing papers, 4.2% of this breakdownCanada: 302 citing papers, 3.5% of this breakdownJapan: 265 citing papers, 3.1% of this breakdownNetherlands: 251 citing papers, 2.9% of this breakdownIndia: 222 citing papers, 2.6% of this breakdownSpain: 197 citing papers, 2.3% of this breakdownFrance: 161 citing papers, 1.8% of this breakdown
0%18.8%Other 30%

Institutions

Fields

  • Medicine63.6%
  • Biochemistry, Genetics and Molecular Biology27%
  • Immunology and Microbiology3%
  • Nursing2.6%
  • Neuroscience0.7%
  • Agricultural and Biological Sciences0.7%
  • Other2.4%

Topics

  • Chronic Kidney Disease and Diabetes7.7%
  • Advanced Glycation End Products research5.1%
  • Diabetes Treatment and Management4.6%
  • COVID-19 Clinical Research Studies2.5%
  • Pancreatic function and diabetes2.2%
  • Diabetes, Cardiovascular Risks, and Lipoproteins2%
  • Other75.9%

Coauthors

All papers

Open in search
  1. Diabetic kidney disease

    Authors: Merlin C. Thomas, Michael Brownlee, Katalin Suszták, Kumar Sharma, Karin Jandeleit‐Dahm, Sophia Zoungas, Peter Rossing, Per‐Henrik Groop, Mark E. Cooper - Nature Reviews Disease Primers 2015 cited by 1,207

  2. Changing epidemiology of type 2 diabetes mellitus and associated chronic kidney disease

    Authors: Merlin C. Thomas, Mark E. Cooper, Paul Zimmet - Nature Reviews Nephrology 2015 cited by 728

  3. The actions of SGLT2 inhibitors on metabolism, renal function and blood pressure

    Authors: Merlin C. Thomas, David Z.I. Cherney - Diabetologia 2018 cited by 353

  4. Transient Intermittent Hyperglycemia Accelerates Atherosclerosis by Promoting Myelopoiesis

    Authors: Michelle Flynn, Michael J. Kraakman, Christos Tikellis, Man K.S. Lee, Nordin M.J. Hanssen, Hélène L. Kammoun, R. J. Pickering, Dragana Dragoljevic, Annas Al‐Sharea, Tessa J. Barrett, Fiona Hortle, Frances L. Byrne, Ellen M. Olzomer, Domenica A. McCarthy, Casper G. Schalkwijk, Josephine M. Forbes, Kyle L. Hoehn, Liza Makowski, Graeme I. Lancaster, Assam El‐Osta, Edward A. Fisher, Ira J. Goldberg, Mark E. Cooper, Prabhakara R. Nagareddy, Merlin C. Thomas, Andrew Murphy - Circulation Research 2020 cited by 166

  5. The Presence and Severity of Chronic Kidney Disease Predicts All-Cause Mortality in Type 1 Diabetes

    Authors: Per‐Henrik Groop, Merlin C. Thomas, John L. Moran, Johan Wadén, Lena M. Thorn, Ville‐Petteri Mäkinen, Milla Rosengård‐Bärlund, Markku Saraheimo, Kustaa Hietala, Outi Heikkilä, Carol Forsblom - Diabetes 2009 cited by 640

  6. An acute fall in estimated glomerular filtration rate during treatment with losartan predicts a slower decrease in long-term renal function

    Authors: Frank A. Holtkamp, Dick de Zeeuw, Merlin C. Thomas, Mark E. Cooper, Pieter A. de Graeff, Hans Hillege, Hans‐Henrik Parving, Barry M. Brenner, Shahnaz Shahinfar, Hiddo J.L. Heerspink - Kidney International 2011 cited by 362

  7. The postprandial actions of GLP-1 receptor agonists: The missing link for cardiovascular and kidney protection in type 2 diabetes

    Authors: Merlin C. Thomas, Melinda T. Coughlan, Mark E. Cooper - Cell Metabolism 2023 cited by 54

  8. Suppression of microRNA-29 Expression by TGF-β1 Promotes Collagen Expression and Renal Fibrosis

    Authors: Bo Wang, Radko Komers, Rosemarie M. Carew, Catherine E. Winbanks, Bei Xu, Michal Herman‐Edelstein, Philip Koh, Merlin C. Thomas, Karin Jandeleit‐Dahm, Paul Gregorevic, Mark E. Cooper, Phillip Kantharidis - Journal of the American Society of Nephrology 2011 cited by 489

  9. Imbalance of the renin–angiotensin system may contribute to inflammation and fibrosis in IBD: a novel therapeutic target?

    Authors: Mayur Garg, Simon G. Royce, Chris Tikellis, Claire Shallue, Duygu Batu, Elena Velkoska, Louise M. Burrell, Sheila K. Patel, Lauren Beswick, Anvesh Jackson, Kaushali Britto, Matthew Lukies, Pavel Sluka, Hady Wardan, Yumiko Hirokawa, Chin Wee Tan, Maree C. Faux, Antony W. Burgess, Patrick Hosking, S. Monagle, Merlin C. Thomas, Peter R. Gibson, John Lubel - Gut 2019 cited by 208

  10. Transactivation of RAGE mediates angiotensin-induced inflammation and atherogenesis

    Authors: R. J. Pickering, Christos Tikellis, Carlos J. Rosado, Despina Tsorotes, Alexandra Dimitropoulos, Monique Smith, Olivier Huet, Ruth M. Seeber, Rekhati S. Abhayawardana, Elizabeth K. M. Johnstone, Jonathan Golledge, Yutang Wang, Karin Jandeleit‐Dahm, Mark E. Cooper, Kevin D. G. Pfleger, Merlin C. Thomas - Journal of Clinical Investigation 2018 cited by 83

  11. A Breaker of Advanced Glycation End Products Attenuates Diabetes-Induced Myocardial Structural Changes

    Authors: Riccardo Candido, Josephine M. Forbes, Merlin C. Thomas, Vicki Thallas, Rachael Dean, Wendy C. Burns, Christos Tikellis, Rebecca H. Ritchie, Stephen M. Twigg, Mark E. Cooper, Louise M. Burrell - Circulation Research 2003 cited by 447

  12. Metabolic Syndrome in Type 1 Diabetes

    Authors: Lena M. Thorn, Carol Forsblom, Johan Fagerudd, Merlin C. Thomas, Kim Pettersson-Fernholm, Markku Saraheimo, Johan Wadén, Mats Rönnback, Milla Rosengård‐Bärlund, Clas-Göran af Björkesten, Marja‐Riitta Taskinen, Per‐Henrik Groop, on behalf of the FinnDiane Study Group - Diabetes Care 2005 cited by 428

  13. Receptor for Advanced Glycation End Products (RAGE) Deficiency Attenuates the Development of Atherosclerosis in Diabetes

    Authors: Aino Soro‐Paavonen, Anna M.D. Watson, Jiaze Li, Karri Paavonen, Audrey Koı̈tka, Anna C. Calkin, David Barit, Melinda T. Coughlan, Brian G. Drew, Graeme I. Lancaster, Merlin C. Thomas, Josephine M. Forbes, Peter P. Nawroth, Angelika Bierhaus, Mark E. Cooper, Karin Jandeleit‐Dahm - Diabetes 2008 cited by 405

  14. Mechanisms of Disease: pathway-selective insulin resistance and microvascular complications of diabetes

    Authors: Per‐Henrik Groop, Carol Forsblom, Merlin C. Thomas - Nature Clinical Practice Endocrinology &#38 Metabolism 2005 cited by 181

  15. Distinguishing Hyperglycemic Changes by Set7 in Vascular Endothelial Cells

    Authors: Jun Okabe, Christian Orlowski, Aneta Balcerczyk, Chris Tikellis, Merlin C. Thomas, Mark E. Cooper, Assam El‐Osta - Circulation Research 2012 cited by 176

  16. The potential and pitfalls of GLP-1 receptor agonists for renal protection in type 2 diabetes

    Authors: Merlin C. Thomas - Diabetes & Metabolism 2017 cited by 104

  17. Angiotensin-Converting Enzyme 2 (ACE2) Is a Key Modulator of the Renin Angiotensin System in Health and Disease

    Authors: Chris Tikellis, Merlin C. Thomas - International Journal of Peptides 2012 cited by 646

  18. Low Testosterone Levels Are Common and Associated with Insulin Resistance in Men with Diabetes

    Authors: Mathis Grossmann, Merlin C. Thomas, Sianna Panagiotopoulos, Ken Sharpe, Richard J. MacIsaac, Sophie Clarke, Jeffrey D. Zajac, George Jerums - The Journal of Clinical Endocrinology & Metabolism 2008 cited by 463

  19. SARS-CoV-2 mouse adaptation selects virulence mutations that cause TNF-driven age-dependent severe disease with human correlates

    Authors: Stefanie M. Bader, James P. Cooney, Dylan Sheerin, George Taiaroa, Leigh Harty, Kathryn Davidson, Liana Mackiewicz, Merle Dayton, Stephen Wilcox, Lachlan Whitehead, Kelly L. Rogers, Smitha R. Georgy, Anna K. Coussens, Samantha L. Grimley, Vincent Corbin, Miranda E. Pitt, Lachlan Coin, R. J. Pickering, Merlin C. Thomas, Cody C. Allison, Julie McAuley, Damian F. J. Purcell, Marcel Doerflinger, Marc Pellegrini - National Academy of Sciences, Proceedings of the National Academy of Sciences 2023 cited by 29

  20. Role of Advanced Glycation End Products in Diabetic Nephropathy

    Authors: Josephine M. Forbes, Mark E. Cooper, Matthew D. Oldfield, Merlin C. Thomas - Journal of the American Society of Nephrology 2003 cited by 345

  21. Cardiac inflammation associated with a Western diet is mediated via activation of RAGE by AGEs

    Authors: Christos Tikellis, Merlin C. Thomas, Brooke E. Harcourt, Melinda T. Coughlan, Josepha Pete, Katarzyna Bialkowski, Adeline Tan, Angelika Bierhaus, Mark E. Cooper, Josephine M. Forbes - American Journal of Physiology-Endocrinology and Metabolism 2008 cited by 130

  22. Targeting the Pathobiology of Diabetic Kidney Disease

    Authors: Merlin C. Thomas - Advances in Chronic Kidney Disease 2021 cited by 50

  23. The Association Between Dietary Sodium Intake, ESRD, and All-Cause Mortality in Patients With Type 1 Diabetes

    Authors: Merlin C. Thomas, John L. Moran, Carol Forsblom, Valma Harjutsalo, Lena M. Thorn, Aila J. Ahola, Johan Wadén, Nina Tolonen, Markku Saraheimo, Daniel Gordin, Per‐Henrik Groop, for the FinnDiane Study Group - Diabetes Care 2011 cited by 362

  24. Nutrient Sensing, Autophagy, and Diabetic Nephropathy

    Authors: Shinji Kume, Merlin C. Thomas, Daisuke Koya - Diabetes 2011 cited by 156